REG - AstraZeneca PLC - Director/PDMR Shareholding

AstraZenecaAnnouncement

27/02/2020 07:00

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200227:nRSa2434Ea

RNS Number : 2434E  AstraZeneca PLC  27 February 2020

27 February 2020 07:00 GMT

 

 

TRANSACTION BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES

Disclosure under Article 19 of the EU Market Abuse Regulation

 

AstraZeneca PLC (the Company) announces that, on 26 February 2020, it was
notified by Tony Mok, a Non-Executive Director of the Company, that, on 26
February 2020, Mr Mok purchased 1,000 of the Company's American Depositary
Shares (ADSs) at a price of $48.00 per ADS. Two ADSs are equivalent to one
Ordinary Share of $0.25 in the Company.

 

The attached notification, made in accordance with the requirements of the EU
Market Abuse Regulation, gives further detail.

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Tony Mok

 2    Reason for the notification

 a)   Position/status                                              Non-Executive Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         AstraZeneca PLC

 b)   LEI                                                          PY6ZZQWO2IZFZC3IOL08

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  AstraZeneca PLC American Depositary Shares

      Identification code

                                                                   CUSIP: 046353108

 b)   Nature of the transaction                                    Purchase of AstraZeneca PLC American Depositary Shares

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   US$48.00  1,000

 

 d)   Aggregated information                                       Not applicable - single transaction

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      26 February 2020

 f)   Place of the transaction                                     NYSE

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Not applicable - single transaction

 

e)

 

Date of the transaction

 

 

26 February 2020

f)

 

Place of the transaction

 

 

NYSE

 

AstraZeneca

AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical
company that focuses on the discovery, development and commercialisation of
prescription medicines, primarily for the treatment of diseases in three
therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and
Respiratory. Based in Cambridge, UK, AstraZeneca operates in over 100
countries and its innovative medicines are used by millions of patients
worldwide. Please visit astrazeneca.com (http://www.astrazeneca.com/) and
follow the Company on Twitter @AstraZeneca (https://twitter.com/AstraZeneca) .

 Media Relations
 Gonzalo Viña                                                                                      +44 203 749 5916
 Rob Skelding                     Oncology                                                         +44 203 749 5821
 Rebecca Einhorn                  Oncology                                                         +1 301 518 4122
 Matt Kent                        BioPharmaceuticals                                               +44 203 749 5906
 Angela Fiorin                    BioPharmaceuticals                                               +44 1223 344 690
 Jennifer Hursit                  Other                                                            +44 203 749 5762
 Christina Malmberg Hägerstrand   Sweden                                                           +46 8 552 53 106
 Michele Meixell                  US                                                               +1 302 885 2677
 Investor Relations
 Thomas Kudsk Larsen                                                                               +44 203 749 5712
 Henry Wheeler                    Oncology                                                         +44 203 749 5797
 Christer Gruvris                 BioPharmaceuticals                                               +44 203 749 5711

                                  (Cardiovascular, Metabolism)
 Nick Stone                       BioPharmaceuticals (Renal) Environmental, Social and Governance  +44 203 749 5716
 Josie Afolabi                    BioPharmaceuticals (Respiratory)                                 +44 203 749 5631

 Tom Waldron                      Other medicines                                                  +44 7385 033 717
 Craig Marks                      Finance                                                          +44 7881 615 764

                                  Fixed income
 Jennifer Kretzmann               Corporate access                                                 +44 203 749 5824

                                  Retail investors
 US toll-free                                                                                      +1 866 381 72 77

Adrian Kemp

Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.   END  DSHUNUVRRWUUUAR